Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.
Concentric Analgesics has raised $20.0M in total funding. The most recent round was Convertible Note. The last funding was announced in January 2022.
Concentric Analgesics's investors include Venrock, Cowen Healthcare Investments, Kern Whelan Capital, Oracle Investment Management Inc..
Concentric Analgesics is headquartered in San Francisco, United States.
Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.
Concentric Analgesics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Concentric Analgesics — Funding & Investors." VCBacked, January 26, 2022, https://www.vcbacked.co/company/concentric-analgesics. Accessed August 14, 2026.
VCBacked. (2022). Concentric Analgesics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/concentric-analgesics
{{cite web |title=Concentric Analgesics — Funding & Investors |url=https://www.vcbacked.co/company/concentric-analgesics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated